Glpclinicscout

GLP-1 Clinic Scout (Tilton Group LLC) — Longitudinal compounded GLP-1 pharmaceutical price index: dated, source-bound weekly observations of provider-specific starting monthly prices for compounded semaglutide and tirzepatide (plus branded Wegovy/Zepbound/Ozempic/Mounjaro list prices), each observation pinned to a dated first-party pricing-page capture with quoted price wording, basis metadata (introductory vs published, monthly vs bundle-equivalent, route), and per-provider review records across a 57-provider live catalog.. Small but unusually clean single-vertical dataset: 57 tracked provid…

Glpclinicscout offers (Alternative, Fundamental) — ~1,300 dated price observations/year (57 live providers × 2 medications × ~11 eligible monthly observations per drug-track per year), growing weekly; current published cohort = 17 eligible semaglutide + 18 tirzepatide monthly observations with 57-provider live catalog coverage; plus 44 evidence guides and 57 structured provider review records. Each observation carries verbatim captured first-party price wording, so text volume scales with the price rows..

Pharmaceutical pricing intelligence and GLP-1 affordability modelling; telehealth/independent-pharmacy competitive price benchmarking and dynamic-pricing feeds; payer and PBM formulary/copay-impact analysis; compounded-drug market sizing and 503a/503b compounding exposure monitoring; FDA enforcement and price-sustainability surveillance; demand forecasting for obesity-medicine supply (API/bulk-order planning); equity research alpha on GLP-1 commercial uptake; ML training for price-extraction and promo-detection models using the dated quote/evidence pairs as ground truth.

Coverage spans US; Pharmaceuticals: Drug Makers, Health Care Technology; alternative, fundamental; equities.